Overall survival of men with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line docetaxel-containing chemotherapy according to their participation (or not) in clinical trials.

被引：0
|
作者：
Goyal, Jatinder
Huang, Peng
Tyagi, Prachi
Oh, Daniel
Carducci, Michael Anthony
Eisenberger, Mario A.
Antonarakis, Emmanuel S.
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.148
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
148
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer
    Goyal, Jatinder
    Nuhn, Philipp
    Huang, Peng
    Tyagi, Prachi
    Oh, Daniel
    Carducci, Michael A.
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    BJU INTERNATIONAL, 2012, 110 (11B) : E575 - E582
  • [2] The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer
    Park, Jong Chul
    Pratz, Caroline F.
    Tesfaye, Anteneh
    Brodsky, Robert A.
    Antonarakis, Emmanuel S.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (01) : 32 - 38
  • [3] The effect of therapeutic anticoagulation on overall survival (OS) in men receiving docetaxel chemotherapy for metastatic castration-resistant prostate cancer (mCRPC)
    Pratz, Caroline F.
    Brodsky, Robert A.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [4] Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth
    de Wit, Ronald
    Tannock, Ian
    Eisenberger, Mario
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 203 - 211
  • [5] Docetaxel rechallenge chemotherapy in metastatic castration-resistant prostate cancer (mCRPC).
    Bracarda, S.
    Sisani, M.
    Rossi, M.
    Galli, L.
    Hamzaj, A.
    Scali, S.
    De Angelis, V.
    Falcone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients
    Caffo, Orazio
    Lo Re, Giovanni
    Sava, Teodoro
    Buti, Sebastiano
    Sacco, Cosimo
    Basso, Umberto
    Zustovich, Fable
    Lodde, Michele
    Perin, Alessandra
    Facchini, Gaetano
    Veccia, Antonello
    Maines, Francesca
    Barile, Carmen
    Fratino, Lucia
    Gernone, Angela
    De Vivo, Rocco
    Pappagallo, Giovanni L.
    Galligioni, Enzo
    FUTURE ONCOLOGY, 2015, 11 (06) : 965 - 973
  • [7] Management of metastatic castration-resistant prostate cancer after first-line docetaxel
    Harrington, J. A.
    Jones, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (14) : 2133 - 2142
  • [8] INTERMITTENT (RECHALLENGE) CHEMOTHERAPY WITH DOCETAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Bracarda, Sergio
    Rossi, Marta
    Hamzaj, Alketa
    De Angelis, Verena
    De Simone, Valeria
    Caserta, Claudia
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2009, 20
  • [9] Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer
    Veccia, Antonello
    Caffo, Orazio
    De Giorgi, Ugo
    Di Lorenzo, Giuseppe
    Ortega, Cinzia
    Scognamiglio, Florinda
    Aieta, Michele
    Facchini, Gaetano
    Mansueto, Giovanni
    Mattioli, Rodolfo
    Procopio, Giuseppe
    Zagonel, Vittorina
    D'Angelo, Alessandro
    Spizzo, Gilbert
    Bortolus, Roberto
    Donini, Maddalena
    Lo Re, Giovanni
    Massari, Francesco
    Vicario, Giovanni
    Zucali, Paolo A.
    Alesini, Daniele
    Bonetti, Andrea
    Mucciarini, Claudia
    Nicodemo, Maurizio
    Berruti, Alfredo
    Fratino, Lucia
    Lodde, Michele
    Messina, Caterina
    Perin, Alessandra
    Santini, Daniele
    Sava, Teodoro
    Tucci, Marcello
    Basso, Umberto
    Maines, Francesca
    Burgio, Luca S.
    Galligioni, Enzo
    FUTURE ONCOLOGY, 2016, 12 (04) : 493 - 502
  • [10] Survival outcome in patients with metastatic castration-resistant prostate cancer according to first-line treatment
    Thurin, Nicolas H.
    Rouyer, Magali
    Jove, Jeremy
    Gross-Goupil, Marine
    Haaser, Thibaud
    Rebillard, Xavier
    Soulie, Michel
    de Pouvourville, Gerard
    Pierres, Marie
    Capone, Camille
    Lamarque, Stephanie
    Bignon, Emmanuelle
    Droz-Perroteau, Cecile
    Moore, Nicholas
    Blin, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 114 - 114
12345